Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-2.8x
Contraction
Streak
2 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | -46.53% |
| Q3 2025 | -46.18% |
| Q2 2025 | 10.10% |
| Q1 2025 | -97.53% |
| Q4 2024 | -14.24% |
| Q3 2024 | -1.86% |
| Q2 2024 | 41.33% |
| Q1 2024 | -339.83% |
| Q4 2023 | 43.56% |
| Q3 2023 | -125.49% |
| Q2 2023 | 46.49% |
| Q1 2023 | 25.43% |
| Q4 2022 | 30.56% |
| Q3 2022 | 2.92% |
| Q2 2022 | -16.80% |
| Q1 2022 | -6.11% |
| Q4 2021 | 8.38% |
| Q3 2021 | -63.76% |
| Q2 2021 | 42.72% |
| Q1 2021 | -62.07% |
| Q4 2020 | 16.68% |
| Q3 2020 | -7.02% |
| Q2 2020 | 16.55% |
| Q1 2020 | -54.73% |
| Q4 2019 | 3.15% |
| Q3 2019 | 6.92% |
| Q2 2019 | 10.22% |
| Q1 2019 | -78.08% |
| Q4 2018 | 23.02% |
| Q3 2018 | -30.99% |
| Q2 2018 | 23.79% |
| Q1 2018 | -21.56% |
| Q4 2017 | -4.58% |
| Q3 2017 | 78.09% |
| Q2 2017 | -38.59% |
| Q1 2017 | -30.02% |
| Q4 2016 | 27.47% |
| Q3 2016 | 17.13% |
| Q2 2016 | -55.59% |
| Q1 2016 | -66935.99% |